| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.01 |